Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease
Clinical trial NCT02244541 · COMPLETED
Trial details
- NCT number
- NCT02244541
- Sponsor
- Anavex Life Sciences Corp.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-11-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.